2013

1.

Schuurs TA, Verweij SP, Weel JF, Ouburg S, Morré SA.

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in an STI population: performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT/NG and the COBAS Amplicor with urine specimens and urethral/cervicovaginal samples.

BMJ Open. 2013 Dec 30;3(12):e003607. doi: 10.1136/bmjopen-2013-003607.

2.

Dukers-Muijrers NH, Speksnijder AG, Morré SA, Wolffs PF, van der Sande MA, Brink AA, van den Broek IV, Werner MI, Hoebe CJ.

Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms.

PLoS One. 2013 Nov 20;8(11):e81236. doi: 10.1371/journal.pone.0081236.

3.

Rúa EC, Drut R, Peña AS.

Non-celiac wheat sensitivity is not a new entity.

Am  J Gastroenterol. 2013 Nov;108(11):1805. doi: 10.1038/ajg.2013.307.

4.

Arranz E, Peña AS, Bernardo D.

Mediators of inflammation and immune responses  in the human gastrointestinal tract.

Mediators Inflamm. 2013;2013:865638. doi: 10.1155/2013/865638.

5.

Broers CJ, Gemke RJ, Morré SA, Weijerman ME, van Furth AM.

Increased production of interleukin-10 in children with Down syndrome upon ex vivo stimulation with Streptococcus pneumoniae.

Pediatr Res. 2014 Jan;75(1-1):109-13.  doi: 10.1038/pr.2013.173.

6.

Smelov V, Novikov A, Brown LJ, Eklund C, Strokova L, Ouburg S, Morre SA, Dillner J.

False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection.

Int J STD AIDS. 2013 Jun;24(6):501-2. doi: 10.1177/0956462412472805.

7.

Geelen TH, Rossen JW, Beerens AM, Poort L, Morré SA, Ritmeester WS, van Kruchten HE, van de Pas MM, Savelkoul PH.

Performance of cobas® 4800 and m2000 real-time™ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and self-collected vaginal specimen.

Diagn Microbiol Infect Dis. 2013 Oct;77(2):101-5. doi: 10.1016/j.diagmicrobio.2013.06.020.

8.

Sanders MS, de Jonge RC, Terwee CB, Heymans MW, Koomen I, Ouburg S, Spanjaard  L, Morré SA, van Furth AM.

Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study.

BMC Infect Dis. 2013 Jul 23;13:340. doi: 10.1186/1471-2334-13-340.

9.

Malogajski J, Brankovic I, Verweij SP, Ambrosino E, van Agtmael MA, Brand A,  Ouburg S, Morré SA.

Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.

Biomed Res Int. 2013;2013:892106. doi: 10.1155/2013/892106.

10.

Bom RJ, Matser A, Bruisten SM, van Rooijen MS, Heijman T, Morré SA, de Vries  HJ, Schim van der Loeff MF.

Multilocus sequence typing of Chlamydia trachomatis among men who have sex with men reveals cocirculating strains not associated with specific subpopulations.

J Infect Dis. 2013 Sep;208(6):969-77. doi: 10.1093/infdis/jit275.

11.

van Well GT, Sanders MS, Ouburg S, Kumar V, van Furth AM, Morré SA.

Single nucleotide polymorphisms in pathogen recognition receptor genes are associated with susceptibility to meningococcal meningitis in a pediatric cohort.

PLoS One.  2013 May 14;8(5):e64252. doi: 10.1371/journal.pone.0064252. Print 2013. PubMed PMID: 23691182; PubMed Central PMCID: PMC3653876.

12.

Verweij SP, Quint KD, Bax CJ, Van Leeuwen AP, Mutsaers JA, Jansen CL, Oostvogel PM, Ouburg S, Morré SA, Peters RP.

Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands.

Epidemiol Infect. 2014 Feb;142(2):409-14. doi: 10.1017/S095026881300071X.

13.

Lal JA, Malogajski J, Verweij SP, de Boer P, Ambrosino E, Brand A, Ouburg S,  Morré SA.

Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health.

Public Health Genomics.  2013;16(1-2):50-61. doi: 10.1159/000346207.

14.

International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A,  Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Kenna TJ, Haroon N, Ferreira MA, Yang J, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Deloukas P, Donnelly P; Australo-Anglo-American Spondyloarthritis Consortium (TASC); Groupe Française d’Etude Génétique des Spondylarthrites (GFEGS); Nord-Trøndelag Health Study (HUNT); Spondyloarthritis Research Consortium of Canada (SPARCC); Wellcome Trust Case Control Consortium 2  (WTCCC2), Bowness P, Gafney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Xu H, Crusius JB, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Videm V, Martin J, Breban M, Reveille JD, Evans DM, Kim TH, Wordsworth BP, Brown MA.

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Nat Genet. 2013 Jul;45(7):730-8. doi: 10.1038/ng.2667.

15.

Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, Trynka G, Raj T, Mirkov MU, Canhao H, Ikari K, Terao C, Okada Y, Wedrén S, Askling J, Yamanaka H, Momohara S, Taniguchi A, Ohmura K, Matsuda F, Mimori T, Gupta N, Kuchroo M, Morgan AW, Isaacs JD, Wilson AG, Hyrich KL, Herenius M, Doorenspleet ME, Tak PP,  Crusius JB, van der Horst-Bruinsma IE, Wolbink GJ, van Riel PL, van de Laar M, Guchelaar HJ, Shadick NA, Allaart CF, Huizinga TW, Toes RE, Kimberly RP, Bridges SL Jr, Criswell LA, Moreland LW, Fonseca JE, de Vries N, Stranger BE, De Jager PL, Raychaudhuri S, Weinblatt ME, Gregersen PK, Mariette X, Barton A, Padyukov L, Coenen MJ, Karlson EW, Plenge RM.

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.

PLoS Genet. 2013 Mar;9(3):e1003394. doi: 10.1371/journal.pgen.1003394.